Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort

Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort

Abstract Background As direct acting antiviral (DAA) therapy is progressively rolled out for patients with hepatitis C virus (HCV) infection, careful scrutiny of HCV epidemiology, diagnostic testing, and access to care is crucial to underpin improvements in delivery of treatment, with the ultimate g...

Full description

Bibliographic Details
Main Authors: Emily Adland, Gerald Jesuthasan, Louise Downs, Victoria Wharton, Gemma Wilde, Anna L. McNaughton, Jane Collier, Eleanor Barnes, Paul Klenerman, Monique Andersson, Katie Jeffery, Philippa C. Matthews
Format: Article
Language:English
Published: BMC 2018-09-01
Series:BMC Infectious Diseases
Subjects:
HCV
Antigen
Antibody
Screening
Genotype
Epidemiology
Online Access:http://link.springer.com/article/10.1186/s12879-018-3367-3

Internet

http://link.springer.com/article/10.1186/s12879-018-3367-3

Similar Items